Gene editing with adeno-associated virus vector offers hope for hereditary deafness

An R75W mutation in the gap junction β2 (GJB2) gene causes severe fragmentation of gap junction plaques, connecting adjacent cells and leading to syndromic hearing loss. In a new experimental study, scientists from Juntendo University in collaboration with researchers from the University of Tokyo have developed an adeno-associated virus (AAV) vector-mediated genome editing approach to repair the R75W mutation.

Knowledge of genetics and genomic medicine is crucial for mental health providers, says study

In a manuscript published in the American Journal of Psychiatry titled “Psychiatric Genetics in Clinical Practice: Essential Knowledge for Mental Health Professionals,” the authors provide updated guidelines on what mental health professionals should know about the latest advances in genetics and how genetics can inform clinical psychiatric practice.

Study explores what motivates LGB parents to have more children

A new study found that only sociodemographic factors—including the parent’s age, number of current children, economic status, and level of religiosity—predict the desire and intention to have more children among lesbian, gay, and bisexual (LGB) parents. The study was led by Dr. Geva Shenkman-Lachberg of the Dina Recanati School of Medicine at Reichman University, in collaboration with Yuval Shaia of Reichman University and Dr. Kfir Ifrah of Ruppin Academic Center.

Testing for just three genes could help prevent 75% of avoidable side effects for certain medications

A new study from Queen Mary University of London found that 9% of all reported adverse drug reactions (ADRs) reported to the UK medicines regulator are associated with medications where side effect risk is partly dependent on the patient’s genes. Of this subset of ADRs, 75% were associated with only three genes that impact how the body processes medication. Genetic testing before prescribing could therefore help avoid ADRs in these cases.